Home » U.S. FDA Seeks Postapproval Hip Implant Studies
U.S. FDA Seeks Postapproval Hip Implant Studies
June 3, 2011
The U.S. Food and Drug Administration (FDA) is asking 21 devicemakers to conduct postapproval studies for their metal-on-metal (MoM) hip implants after reports of high ion concentrations of cobalt and chromium in the blood of patients using the devices.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor